Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY ® ...
Hosted on MSN
Cabaletta Bio Presents Promising RESET-PV Trial Data
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cabaletta Bio ( (CABA)) has shared an ...
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic profile of a newly developed crystal form of buntanetap, ...
News of an easing of U.S.-China trade tensions has not only added another leg up for the stock market but it's finally notably impacted an important indicator of market angst. The Cboe Volatility ...
The most common chronic progressive fibrosing ILD is IPF.1,2 PPF is another form of progressive fibrotic lung disease that ...
In October 2025, BioWorld tracked 252 clinical trial updates across phases I-III, roughly in line with September’s 230 but markedly higher than the 95 logged in August. Of those, 27 phase III studies ...
The Tribunal held that the revision was invalid because the assessment caused no loss to Revenue, as agricultural income was ...
U.S.-based Barinthus Biotherapeutics is entering a reverse merger with U.K. biotech Clywedog Therapeutics, with the combined company expected to advance three clinical assets across diabetes and ...
Prime Minister Benjamin Netanyahu’s flight to the US took a circuitous route in an apparent effort to avoid countries that could enforce an outstanding arrest warrant against him for alleged war ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback